RxDoctor Payments Data

Kenneth John Lim, MD

Family Medicine · Orlando, FLNPI 1679705974

Payments from drug & device makers

$1,572in general payments, 2019–2025

Across 84 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$297
  • Pfizer$271
  • AstraZeneca$182
  • Exact Sciences$180
  • GSK$117
  • Amgen$80
  • plus $445 from 12 others

What the payments were for

  • Food & beverage$1,55599%
  • Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,572 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$47,025
Medicare patients
113
Services billed
466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$62,650
MounjaroTirzepatide38$60,713
JardianceEmpagliflozin33$49,553
EliquisApixaban21$33,440
RybelsusSemaglutide19$32,973
KerendiaFinerenone21$21,304
FarxigaDapagliflozin Propanediol13$16,633
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,664
Atorvastatin Calcium277$2,534
Albuterol Sulfate HfaAlbuterol Sulfate41$1,445
Lidocaine16$1,295
Levothyroxine Sodium128$1,243
Gabapentin105$1,239
Ultra-Fine Short Pen NeedlePen Needle, Diabetic12$1,210
SynthroidLevothyroxine Sodium14$1,118

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$297$95,62366 claims
Lilly USA, LLCMounjaro$66$60,71338 claims
Boehringer IngelheimJardiance$37$49,55333 claims
PfizerEliquis$271$33,44021 claims
BayerKerendia$22$21,30421 claims
AstraZenecaFarxiga$182$16,63313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →